semaglutide weight watchers WeightWatchers to offer compounded weight-loss drugs, Ozempic and Wegovy WeightWatchers is getting in on

ACT 1: Beyond GLP-1 Why Triple Agonists Are Rewriting the Weight Loss Ceiling To understand why newer drugs like Retatrutide are generating so much excitement in obesity medicine, you first need to understand what current medications actually do and where their limitations lie

triglycerides decreased by 31%

Kidney health In people who have type 2 diabetes and chronic kidney disease, Wegovy can lower the chance of: kidney failure by 24% major cardiovascular events by 18% A meta-analysis also found that in people with type 2 diabetes GLP-1 medications, including semaglutide, could reduce the chances of: kidney-related health events by 18% kidney failure by 16% Brain health Wegovy could have positive effects on brain health, specifically in the development of Alzheimers disease and addiction

Zeng, Q